ARCA biopharma's (ABIO) Richard Brewer Will Assume Role of Chairman And Resign As CEO
ARCA biopharma, Inc. (Nasdaq: ABIO) announced changes to its management team to reflect the Company's recent change in commercial strategy to seek alternatives for the potential commercialization of Gencaro. Richard B. Brewer will assume the role of Chairman of the Board of Directors and resign as Chief Executive Officer. Michael R. Bristow, will become President and Chief Executive Officer, a position he previously held with ARCA prior to Mr. Brewer joining the Company. Dr. Bristow will resign as Chairman but will remain a member of the Board of Directors. These changes will be effective on July 10, 2009.
You May Also Be Interested In
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- McDonald's (MCD) Promotes Dave Hoffmann to President of APMEA
- AngioDynamics (ANGO) Appoints George Bourne as Tech Chief
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
